AL58805
Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name AL58805
Trade Name
Synonyms AL 58805|AL-58805
Drug Descriptions

Limited information is currently available on AL58805, a putative dual-target PI3K/mTOR inhibitor (Sep 2026).

DrugClasses mTOR Inhibitor 52 PI3K Inhibitor (Pan) 44
CAS Registry Number NA
NCIT ID NA

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
AL58805 AL58805 0 0
AL58805 + AL8326 AL58805 AL8326 0 1
AL58805 + Anlotinib AL58805 Anlotinib 0 1
AL58805 + Eribulin AL58805 Eribulin 0 1
AL58805 + Fulvestrant AL58805 Fulvestrant 0 1
AL58805 + Lomustine + Temozolomide AL58805 Lomustine Temozolomide 0 1


Additional content available in Icon for CKB-BoostCKB BOOST